Ads
related to: keytruda- Dosing & Administration
Get Recommended
Dosing
- Patient Support
Complete Patient Support
And Product Information
- Peer Videos
Watch Videos Sharing
Clinical And Patient Experiences
- Clinical Trial Results
Review Data From
3 Clinical Studies
- Mechanism Of Action
Details About Therapy
MOA
- Unique Therapy
Get Information At The
Physician Site
- Dosing & Administration
Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 12 hours agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 6 days agoMerck MRK announced that it is discontinuing a cohort of the phase III study evaluating a...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 3 days agoJ&J JNJ announced that it will acquire a private biotech, Proteologix, which will add the latter’s...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 7 days agoUS pharmaceutical company Merck & Co Inc (MSD) has discontinued a Phase III trial investigating a...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 7 days agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agoThe company is partnered with Merck on a cancer vaccine. The duo already has promising results in...
Top Stock Reports for Broadcom, Merck & Airbnb
Zacks via Yahoo Finance· 5 days agoToday's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Merck & Co., Inc. (MRK) and Airbnb, Inc. (ABNB).
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 4 days agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
...Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab)...
Benzinga· 7 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that
Earnings call: AIM ImmunoTech highlights Q1 2024 progress on cancer trials
Investing.com· 5 days agoAIM ImmunoTech (NYSE: AIM ) Inc. (NYSE American: AIM) provided an optimistic update during its first...
Ad
related to: keytruda